95 - Update on Antifungal Vaccines: How Close Are We?

Speaker(s)

• 

  Bridget Barker, MS PhD

  Associate Professor
  Northern Arizona University
  Flagstaff, Arizona

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  John Edwards, Jr., MD

  Professor of Medicine Emeritus
  Lundquist Institute for Innovative Biomedical Research at Harbor/UCLA
  Palos Verdes, California

  Disclosure: NovaDigm Therapeutics : Advisor or Review Panel member (Status: Ongoing), Co-founder (Status: Ongoing), Consultant (Status: Ongoing), Grant/Research Support (Status: Ongoing), Shareholder (Status: Ongoing)
• 

  Jennifer Lodge, PhD

  Vice Chancellor/Associate Dean/Professor
  Washington University
  St. Louis, Missouri

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-20-479-H04-P

Learning Objectives:

• summarize fungal antigens under investigation for vaccination strategies
• assess the impact of fungal vaccination on mucosal Candida infections
• describe fungal vaccines in clinical development and trials

Presentations:

• 2:45pm – 4:00pm EDT

  Update on Coccidioides Vaccination
  Bridget M. Barker, MS PhD – Northern Arizona University
• 2:45pm – 4:00pm EDT

  Update on Cryptococcus Vaccination
  Jennifer Lodge, PhD – Washington University
• 2:45pm – 4:00pm EDT

  Vaccination Strategies for C. Albicans and C. Auris
  John E. Edwards, Jr., MD – Lundquist Institute for Innovative Biomedical Research at Harbor/UCLA